Net Assets for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's latest reported net assets is $52.13B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet AssetsSwitch metric
Latest period
$52.13B
YoY change
+9.4%
5Y CAGR
+9.7%
Peak year (2025)
$52.13B
Latest annual
$52.13B
Net Assets history chart for Abbott Laboratories (ABT) from 1985 to 2025
Net Assets history table for Abbott Laboratories (ABT) from 1985 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $52.13B | +9.4% | ||
| 2024 | $47.66B | +23.5% | ||
| 2023 | $38.60B | +5.2% | ||
| 2022 | $36.69B | +2.5% | ||
| 2021 | $35.80B | +9.2% | ||
| 2020 | $32.78B | +5.5% | ||
| 2019 | $31.09B | +1.8% | ||
| 2018 | $30.52B | -1.2% | ||
| 2017 | $30.90B | +50.4% | ||
| 2016 | $20.54B | -3.2% | ||
| 2015 | $21.21B | -1.5% | ||
| 2014 | $21.53B | -14.5% | ||
| 2013 | $25.17B | -5.8% | ||
| 2012 | $26.72B | +9.3% | ||
| 2011 | $24.44B | +7.8% | ||
| 2010 | $22.68B | -2.0% | ||
| 2009 | $23.14B | +32.4% | ||
| 2008 | $17.48B | -1.7% | ||
| 2007 | $17.78B | +26.5% | ||
| 2006 | $14.05B | -2.5% | ||
| 2005 | $14.42B | +0.6% | ||
| 2004 | $14.33B | +9.6% | ||
| 2003 | $13.07B | +22.6% | ||
| 2002 | $10.66B | +17.7% | ||
| 2001 | $9.06B | +5.7% | ||
| 2000 | $8.57B | +15.4% | ||
| 1999 | $7.43B | +30.0% | ||
| 1998 | $5.71B | +14.3% | ||
| 1997 | $5.00B | +3.7% | ||
| 1996 | $4.82B | +9.6% | ||
| 1995 | $4.40B | +8.6% | ||
| 1994 | $4.05B | +10.2% | ||
| 1993 | $3.67B | +9.8% | ||
| 1992 | $3.35B | +4.5% | ||
| 1991 | $3.20B | +13.0% | ||
| 1990 | $2.83B | +3.9% | ||
| 1989 | $2.73B | +10.6% | ||
| 1988 | $2.46B | +17.7% | ||
| 1987 | $2.09B | +17.7% | ||
| 1986 | $1.78B | -4.9% | ||
| 1985 | $1.87B | — |
Net Assets values are taken from Abbott Laboratories's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Abbott Laboratories (ABT) net assets totalled $52.13B – grew 9.4% year-over-year.
Through 2020–2025 (5 years), Abbott Laboratories net assets delivered a +9.7% annualised rate; sustaining 7 straight years of year-over-year growth.
The dataset's maximum net assets sits at $52.13B (2025); the minimum reading of $1.78B dates to 1986.
Abbott Laboratories (ABT) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $50.64B.
Abbott Laboratories Net Assets by Year
Abbott Laboratories Net Assets 2025: $52.13B
Abbott Laboratories net assets in 2025 was $52.13B, grew 9.4% from 2024. This figure represents the highest annual value in the available history.
Abbott Laboratories Net Assets 2024: $47.66B
Abbott Laboratories net assets in 2024 was $47.66B, grew 23.5% from 2023.
Abbott Laboratories Net Assets 2023: $38.60B
Abbott Laboratories net assets in 2023 was $38.60B, grew 5.2% from 2022.
Abbott Laboratories Net Assets 2022: $36.69B
Abbott Laboratories net assets in 2022 was $36.69B, edged up 2.5% from 2021.
Abbott Laboratories Net Assets 2021: $35.80B
Abbott Laboratories net assets in 2021 was $35.80B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — Net Assets
Companies in the same sector as Abbott Laboratories, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is Abbott Laboratories's net assets?
- Latest reported net assets for Abbott Laboratories (ABT) is $52.13B (period ending December 31, 2025).
How has Abbott Laboratories net assets changed year-over-year?
- Abbott Laboratories (ABT) net assets changed +9.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories net assets?
- Abbott Laboratories (ABT) net assets compound annual growth rate is +9.7% over the most recent 5 years available.
When did Abbott Laboratories net assets hit its highest annual value?
- Abbott Laboratories net assets reached its highest annual value of $52.13B in 2025.
What was Abbott Laboratories net assets in 2024?
- Abbott Laboratories (ABT) net assets in 2024 was $47.66B.
What was Abbott Laboratories net assets in 2025?
- Abbott Laboratories (ABT) net assets in 2025 was $52.13B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.